Circulatory Assist Devices 2000: An Update
dc.contributor.author | Dyke, David B. S. | en_US |
dc.contributor.author | Pagani, Francis D. | en_US |
dc.contributor.author | Aaronson, Keith D. | en_US |
dc.date.accessioned | 2010-06-01T18:12:48Z | |
dc.date.available | 2010-06-01T18:12:48Z | |
dc.date.issued | 2000-09 | en_US |
dc.identifier.citation | Dyke, David B.S . ; Pagani, Francis D . ; Aaronson, Keith D . (2000). "Circulatory Assist Devices 2000: An Update." Congestive Heart Failure 6(5): 259-271. <http://hdl.handle.net/2027.42/71424> | en_US |
dc.identifier.issn | 1527-5299 | en_US |
dc.identifier.issn | 1751-7133 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/71424 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=12189287&dopt=citation | en_US |
dc.format.extent | 1238339 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | CHF, Inc. | en_US |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | 2000 by CHF, Inc. | en_US |
dc.title | Circulatory Assist Devices 2000: An Update | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationother | From the Division of Cardiology | en_US |
dc.contributor.affiliationother | the Section of Cardiac Surgery, | en_US |
dc.identifier.pmid | 12189287 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/71424/1/j.1527-5299.2000.80165.x.pdf | |
dc.identifier.doi | 10.1111/j.1527-5299.2000.80165.x | en_US |
dc.identifier.source | Congestive Heart Failure | en_US |
dc.identifier.citedreference | Dale HH, Schuster EHJ. A double perfusion pump. J Physiol. 1928; 64: 356 – 364. | en_US |
dc.identifier.citedreference | DeBakey ME. A simple continuous flow blood transfusion instrument. New Orleans Med Surg J. 1934; 87: 386 – 389. | en_US |
dc.identifier.citedreference | DeVries WC, Joyce LD. The artificial heart. Clin Symposia. 35 ( 6 ): 1 – 32. | en_US |
dc.identifier.citedreference | Gibbon JH Jr. Application of a mechanical heart and lung apparatus to cardiac surgery. 1954; 37: 171 – 180. | en_US |
dc.identifier.citedreference | Akutsu T, Kolff WJ. Permanent substitutes for valves and hearts. Trans Am Soc Artif Intern Organs. 1958; 4: 230 – 235. | en_US |
dc.identifier.citedreference | Kantrowitz A, Tjonneland S, Freed PS, et al. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. JAMA. 1968; 203 ( 2 ): 113 – 118. | en_US |
dc.identifier.citedreference | Cooley DA, Liotta D, Hallman GL, et al. Orthotopic cardiac prosthesis for two-staged cardiac replacement. Am J Cardiol. 1969; 24 ( 5 ): 723 – 730. | en_US |
dc.identifier.citedreference | DeVries WC, Anderson JL, Joyce LD, et al. Clinical use of the total artificial heart. N Engl J Med. 1984; 310 ( 5 ): 273 – 278. | en_US |
dc.identifier.citedreference | Goldstein DJ, Oz MC, Rose EA. Implantable left ventricular assist devices. N Engl J Med. 1998; 339 ( 21 ): 1522 – 1533. | en_US |
dc.identifier.citedreference | Rose EA, Moskowitz AJ, Packer M, et al. The REMATCH trial: Rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure. Ann Thorac Surg. 1999; 67 ( 3 ): 723 – 730. | en_US |
dc.identifier.citedreference | Reinhartz O, Farrar DJ, Hershon JH, et al. Importance of preoperative liver function as a predictor of survival in patients supported with Thoratec ventricular assist devices as a bridge to transplantation. J Thorac Cardiovasc Surg. 1998; 116 ( 4 ): 633 – 640. | en_US |
dc.identifier.citedreference | Pagani FD, Lynch W, Swaniker F, et al. Extracorporeal life support to left ventricular assist device bridge to heart transplant: A strategy to optimize survival and resource utilization. Circulation. 1999; 100 ( suppl 19 ): II206 – II210. | en_US |
dc.identifier.citedreference | McCarthy PM, Smedira NO, Vargo RL, et al. One hundred patients with the HeartMate left ventricular assist device: Evolving concepts and technology. J Thorac Cardiovasc Surg. 1998; 115 ( 4 ): 904 – 912. | en_US |
dc.identifier.citedreference | Frazier OH, Macris MP, Myers TJ, et al. Improved survival after extended bridge to cardiac transplantation. Ann Thorac Surg. 1994; 57 ( 6 ): 1416 – 1422. | en_US |
dc.identifier.citedreference | Oz MC, Goldstein DJ, Pepino P, et al. Screening scale predicts patients successfully receiving long-term implantable left ventricular assist devices. Circulation. 1995; 92 ( suppl 9 ): II169 – II173. | en_US |
dc.identifier.citedreference | Mehta SM, Aufiero TX, Pae WE Jr, et al. Mechanical ventricular assistance: An economical and effective means of treating end-stage heart disease. Ann Thorac Surg. 1995; 60 ( 2 ): 284 – 290. | en_US |
dc.identifier.citedreference | Morales DL, Catanese KA, Helman DN, et al. Six-year experience of caring for forty-four patients with a left ventricular assist device at home: Safe, economical, necessary. J Thorac Cardiovasc Surg. 2000; 119 ( 2 ): 251 – 259. | en_US |
dc.identifier.citedreference | Gelijns AC, Richards AF, Williams DL, et al. Evolving costs of long-term left ventricular assist device implantation. Ann Thorac Surg. 1997; 64 ( 5 ): 1312 – 1319. | en_US |
dc.identifier.citedreference | Moscucci M, Lynch W, Swaniker F, et al. Atrial balloon septostomy in the management and prevention of pulmonary hemorrhage in patients requiring extracorporeal life support. Extracorporeal Life Support Organization 9th annual meeting, Ann Arbor, MI; 1999. | en_US |
dc.identifier.citedreference | Poirier VL. Worldwide experience with the TCI HeartMate system: Issues and future perspective. Thorac Cardiovasc Surg. 1999; 47 ( suppl 2 ): 316 – 320. | en_US |
dc.identifier.citedreference | Rose EA, Levin HR, Oz MC, et al. Artificial circulatory support with textured interior surfaces: A counterintuitive approach to minimizing thromboembolism. Circulation. 1994; 90 ( 5 pt II ): II87 – II91. | en_US |
dc.identifier.citedreference | Arabia FA, Smith RG, Rose DS, et al. Success rates of long-term circulatory assist devices used currently for bridge to heart transplantation. ASAIO J. 1996; 42 ( 5 ): M542 – M546. | en_US |
dc.identifier.citedreference | Argenziano M, Choudhri AF, Moazami N, et al. Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension. Ann Thorac Surg. 1998; 65 ( 2 ): 340 – 345. | en_US |
dc.identifier.citedreference | Hare JM, Shernan SK, Body SC, et al. Influence of inhaled nitric oxide on systemic flow and ventricular filling pressure in patients receiving mechanical circulatory assistance ( published erratum. Circulation. 1997;96(3):1065 ). Circulation. 1997; 95 ( 9 ): 2250 – 2253. | en_US |
dc.identifier.citedreference | Loh E, Stamler JS, Hare JM, et al. Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction. Circulation. 1994; 90 ( 6 ): 2780 – 2785. | en_US |
dc.identifier.citedreference | Oz MC, Rose EA, Slater J, et al. Malignant ventricular arrhythmias are well tolerated in patients receiving long-term left ventricular assist devices. J Am Coll Cardiol. 1994; 24 ( 7 ): 1688 – 1691. | en_US |
dc.identifier.citedreference | Myers TJ, McGee MG, Zeluff BJ, et al. Frequency and significance of infections in patients receiving prolonged LVAD support. ASAIO Trans. 1991; 37: M283 – M285. | en_US |
dc.identifier.citedreference | Frazier OH, Duncan JM, Radovancevic B, et al. Successful bridge to heart transplantation with a new left ventricular assist device. J Heart Lung Transplant. 1992; 11: 530 – 537. | en_US |
dc.identifier.citedreference | Kormos RL, Murali S, Dew A, et al. Chronic mechanical circulatory support: Rehabilitation, low morbidity, and superior survival. Ann Thorac Surg. 1994; 57: 51 – 58. | en_US |
dc.identifier.citedreference | Argenziano M, Catanese KA, Moazami N, et al. The influence of infection on survival and successful transplantation in patients with left ventricular assist devices. J Heart Lung Transplant. 1997; 16 ( 8 ): 822 – 831. | en_US |
dc.identifier.citedreference | Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. Circulation. 1997; 96 ( 1 ): 358 – 366. | en_US |
dc.identifier.citedreference | Lavee J, Kormos RL, Duquesnoy RJ, et al. Influence of panelreactive antibody and lymphocytotoxic crossmatch on survival after heart transplantation. J Heart Lung Transplant. 1991; 10 ( 6 ): 921 – 929. | en_US |
dc.identifier.citedreference | Moazami N, Itescu S, Williams MR, et al. Platelet transfusions are associated with the development of anti-major histocompatibility complex class I antibodies in patients with left ventricular assist support. J Heart Lung Transplant. 1998; 17 ( 9 ): 876 – 880. | en_US |
dc.identifier.citedreference | Stringham JC, Bull DA, Fuller TC, et al. Avoidance of cellular blood product transfusions in LVAD recipients does not prevent HLA allosensitization. J Heart Lung Transplant. 1999; 18 ( 2 ): 160 – 165. | en_US |
dc.identifier.citedreference | Tsau PH, Arabia FA, Toporoff B, et al. Positive panel reactive antibody titers in patients bridged to transplantation with a mechanical assist device: Risk factors and treatment. ASAIO J. 1998; 44 ( 5 ): M634 – M637. | en_US |
dc.identifier.citedreference | Pagani FD, Dyke DB, Wright S, et al. Development of anti-major histocompatibility complex class I or II antibodies following LVAD implant: Effects on subsequent allograft rejection and survival (abstract). J Heart Lung Transplant. 2000; 19 ( 1 ): 57. | en_US |
dc.identifier.citedreference | Icenogle TB, Smith RG, Cleavinger M, et al. Thromboembolic complications of the Symbion AVAD System. Artificial Organs. 1989; 13 ( 6 ): 532 – 538. | en_US |
dc.identifier.citedreference | Levinson MM, Smith RG, Cork RC, et al. Thromboembolic complications of the Jarvik-7 total artificial heart: Case report. Artificial Organs. 1986; 10 ( 3 ): 236 – 244. | en_US |
dc.identifier.citedreference | Wagner WR, Johnson PC, Kormos RL, et al. Evaluation of bioprosthetic valve-associated thrombus in ventricular assist device patients. Circulation. 1993; 88 ( 5 pt 1 ): 2023 – 2029. | en_US |
dc.identifier.citedreference | Farrar DJ, Hill JD. Univentricular and biventricular Thoratec VAD support as a bridge to transplantation. Ann Thorac Surg. 1993; 55 ( 1 ): 276 – 282. | en_US |
dc.identifier.citedreference | Kormos RL, Murali S, Dew MA, et al. Chronic mechanical circulatory support: Rehabilitation, low morbidity, and superior survival. Ann Thorac Surg. 1994; 57 ( 1 ): 51 – 57. | en_US |
dc.identifier.citedreference | Murali S. Mechanical circulatory support with the Novacor LVAS: World-wide clinical results. Thorac Cardiovasc Surg. 1999; 47 ( suppl 2 ): 321 – 325. | en_US |
dc.identifier.citedreference | Ramasamy N, Wheeldon D, Jansen P, et al. Reduction of embolic complications in left ventricular assist systems (LVAS) recipients: Impact of inflow conduit design (abstract). J Heart Lung Transplant. 2000; 19 ( 1 ): 58. | en_US |
dc.identifier.citedreference | Szefner J. Control and treatment of hemostasis in cardiovascular surgery. The experience of La Pitie Hospital with patients on total artificial heart. Int J Artificial Organs. 1995; 18 ( 10 ): 633 – 648. | en_US |
dc.identifier.citedreference | Johnson KE, Prieto M, Joyce LD, et al. Summary of the clinical use of the Symbion total artificial heart: A registry report. J Heart Lung Transplant. 1992; 11 ( 1pt1 ): 103 – 116. | en_US |
dc.identifier.citedreference | Copeland JG III, Arabia FA, Banchy ME, et al. The Cardio-West total artificial heart bridge to transplantation: 1993 to 1996 national trial. Ann Thorac Surg. 1998; 66 ( 5 ): 1662 – 1669. | en_US |
dc.identifier.citedreference | 47 HeartMate LVAS Clinical Results, January 2000. Data on file with Thermo Cardiosystems Inc. | en_US |
dc.identifier.citedreference | Copeland JG, Arabia FA, Smith RG, et al. Arizona experience with CardioWest total artificial heart bridge to transplantation. Ann Thorac Surg. 1999; 68 ( 2 ): 756 – 760. | en_US |
dc.identifier.citedreference | Kormos RL, Ramasamy N, Sit S et al. for the U.S. Multicenter Investigators. Bridge-to-transplant (BTT) experience with the Novacor Left Ventricular Assist System (LVAS): Results of a multicenter study. J Heart Lung Transplant. 1999; 18 ( 1 ): 63. | en_US |
dc.identifier.citedreference | 50 Thoratec VAD System Clinical Monograph. January, 2000. | en_US |
dc.identifier.citedreference | Arabia FA, Smith RG, Rose DS, et al. Success rates of longterm circulatory assist devices used currently for bridge to transplantation. ASAIO J. 1996; 42 ( 5 ): M542 – M546. | en_US |
dc.identifier.citedreference | Frazier OH, Benedict CR, Radovancevic B, et al. Improved left ventricular function after chronic left ventricular unloading. Ann Thorac Surg. 1996; 62 ( 3 ): 675 – 681. | en_US |
dc.identifier.citedreference | Dipla K, Mattiello JA, Jeevanandam V, et al. Myocyte recovery after mechanical circulatory support in humans with endstage heart failure. Circulation. 1998; 97 ( 23 ): 2316 – 2322. | en_US |
dc.identifier.citedreference | Delgado R III, Radovancevic B, Massin EK, et al. Neurohormonal changes after implantation of a left ventricular assist system. ASAIO J. 1998; 44 ( 4 ): 299 – 302. | en_US |
dc.identifier.citedreference | Muller J, Wallukat G, Weng YG, et al. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation. 1997; 96 ( 2 ): 542 – 549. | en_US |
dc.identifier.citedreference | Mancini DM, Beniaminovitz A, Levin H, et al. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation. 1998; 98 ( 22 ): 2383 – 2389. | en_US |
dc.identifier.citedreference | 57 Abiomed Annual Report, 1998. Danvers, MA. | en_US |
dc.identifier.citedreference | Wieselthaler GM, Schima H, Hiesmayr M, et al. First clinical experience with the DeBakey VAD continuous-axial-flow pump for bridge to transplantation. Circulation. 2000; 101 ( 4 ): 356 – 359. | en_US |
dc.identifier.citedreference | Westaby S, Katsumata T, Houel R, et al. Jarvik 2000 heart: Potential for bridge to myocyte recovery. Circulation. 1998; 98 ( 15 ): 1568 – 1574. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.